Estimations des analystes de Wall Street pour Actinium Pharmaceuticals, Inc. (ATNM): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-13 | $-0.27 | ||
| 2026-08-07 | $0.89 | $-0.20 | +545.0% |
| 2026-05-08 | $-0.18 | $-0.22 | +18.2% |
| 2026-03-30 | $-0.19 | $-0.19 | -1.8% |
| 2025-11-14 | $-0.16 | $-0.25 | +36.0% |
| 2025-08-08 | $-0.22 | $-0.32 | +31.2% |
| 2025-05-09 | $-0.51 | $-0.26 | -96.2% |
| 2025-03-31 | $-0.21 | $-0.37 | +43.2% |
Ratios de valorisation
| Ratio P/E | 4.33 |
| Prix / Valeur comptable | 1.62 |
| EV / EBITDA | 0.28 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | 0 | 0 | 0 | 0 | 0 | $1.1M | $1.0M | $81000 | 0 | $90000 |
| Coût des Ventes | $77523 | $55938 | $50721 | $420089 | $447000 | $524000 | 0 | 0 | $811000 | 0 |
| Marge Brute | -$77523 | -$55938 | -$50721 | -$420089 | -$447000 | $620000 | $1.0M | $81000 | -$811000 | $90000 |
| R&D | $17.5M | $17.7M | $17.1M | $16.5M | $16.1M | $17.5M | $23.1M | $38.7M | $30.0M | $21.1M |
| Frais Généraux | $9.3M | $9.2M | $6.7M | $5.1M | $6.3M | $8.1M | $12.0M | $13.3M | $12.1M | $15.2M |
| Charges Opérationnelles | $26.8M | $26.9M | $23.8M | $21.7M | $21.9M | $25.6M | $35.1M | $52.0M | $41.3M | $36.3M |
| Résultat Opérationnel | -$26.8M | -$26.9M | -$23.8M | -$22.1M | -$22.4M | -$25.0M | -$34.1M | -$51.9M | -$42.1M | -$36.2M |
| EBITDA | -$26.8M | -$26.9M | -$23.8M | -$21.5M | -$21.8M | -$24.2M | -$32.3M | -$48.0M | -$37.4M | -$33.1M |
| Charges d'Intérêt | $5007 | $5430 | $173359 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Résultat Avant Impôts | -$24.3M | -$26.6M | -$23.7M | -$21.9M | -$22.2M | -$24.8M | -$33.0M | -$48.8M | -$38.2M | -$33.9M |
| Impôts | $5007 | 0 | $173359 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Résultat Net | -$24.3M | -$26.6M | -$23.7M | -$21.9M | -$22.2M | -$24.8M | -$33.0M | -$48.8M | -$38.2M | -$33.9M |
| BPA | $-15.06 | $-11.96 | $-6.69 | $-4.37 | $-1.83 | $-1.20 | $-1.37 | $-1.83 | $-1.27 | $-1.09 |
| BPA Dilué | $-15.06 | $-11.96 | $-6.69 | $-4.37 | $-1.83 | $-1.20 | $-1.37 | $-1.83 | $-1.27 | $-1.09 |
| Actions en Circulation (Diluées) | $1.6M | $2.2M | $3.5M | $5.0M | $12.1M | $20.6M | $24.1M | $26.6M | $30.1M | $31.2M |
Prix
| Prix | $1.24 |
| Capitalisation | $39M |
| Bourse | AMEX |
| Pays | US |
Entreprises liées: ANVS · FGEN · KZR · LVTX · OKUR · PDSB · RVPH
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ATNM: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions